NCT04706962 : Clinical Trial Detail - Cancer Knowledgebase (CKB)

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT04706962
Title	TH1902 in Patients With Advanced Solid Tumors
Recruitment	Active, not recruiting
Gender	both
Phase	Phase I
Variant Requirements	No
Sponsors	Theratechnologies
Indications	fallopian tube carcinoma prostate cancer Advanced Solid Tumor progesterone-receptor positive breast cancer ovary epithelial cancer estrogen-receptor positive breast cancer lung small cell carcinoma endometrial cancer skin melanoma peritoneal carcinoma ovary serous adenocarcinoma triple-receptor negative breast cancer thyroid cancer
Therapies	TH1902
Age Groups:	adult \| senior
Covered Countries	USA \| CAN

Filter rows:

Showing 1 to 6 of 6 entries

Facility	City	State	Zip	Country	Details
Centre Hospitalier de l'Université de Montréal (CHUM)	Montréal	Quebec	H2X 0A9	Canada	Details
Karmanos Cancer Institute	Detroit	Michigan	48201	United States	Details
Mary Crowley Cancer Research	Dallas	Texas	75230	United States	Details
Pennsylvania Cancer Specialists Research Institute	Gettysburg	Pennsylvania	17325	United States	Details
START Midwest	Grand Rapids	Michigan	49546	United States	Details
University of Texas MD Anderson Cancer Center	Houston	Texas	77030	United States	Details

Showing 1 to 6 of 6 entries

Filter rows:

*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field

NCT04706962Clinical Trial Detail